DPP4 and Miyoshi myopathy: We recently identified that CD26 is intensely expressed in human osteoclasts (OCs) in osteolytic bone tumors, including MM, and that huCD26mAb, a humanized IgG1 monoclonal antibody that directly targets CD26, inhibits human OC differentiation29.